Literature DB >> 27791019

Central role for melanocortin-4 receptors in offspring hypertension arising from maternal obesity.

Anne-Maj S Samuelsson1, Amandine Mullier2, Nuria Maicas2, Nynke R Oosterhuis3, Sung Eun Bae2, Tatiana V Novoselova4, Li F Chan4, Joaquim M Pombo2, Paul D Taylor2, Jaap A Joles3, Clive W Coen2, Nina Balthasar5, Lucilla Poston2.   

Abstract

Melanocortin-4 receptor (Mc4r)-expressing neurons in the autonomic nervous system, particularly in the paraventricular nucleus of the hypothalamus (PVH), play an essential role in blood pressure (BP) control. Mc4r-deficient (Mc4rKO) mice are severely obese but lack obesity-related hypertension; they also show a reduced pressor response to salt loading. We have previously reported that lean juvenile offspring born to diet-induced obese rats (OffOb) exhibit sympathetic-mediated hypertension, and we proposed a role for postnatally raised leptin in its etiology. Here, we test the hypothesis that neonatal hyperleptinemia due to maternal obesity induces persistent changes in the central melanocortin system, thereby contributing to offspring hypertension. Working on the OffOb paradigm in both sexes and using transgenic technology to restore Mc4r in the PVH of Mc4rKO (Mc4rPVH) mice, we have now shown that these mice develop higher BP than Mc4rKO or WT mice. We have also found that experimental hyperleptinemia induced in the neonatal period in Mc4rPVH and WT mice, but not in the Mc4rKO mice, leads to heightened BP and severe renal dysfunction. Thus, Mc4r in the PVH appears to be required for early-life programming of hypertension arising from either maternal obesity or neonatal hyperleptinemia. Early-life exposure of the PVH to maternal obesity through postnatal elevation of leptin may have long-term consequences for cardiovascular health.

Entities:  

Keywords:  developmental programming; hypertension; maternal obesity; melanocortin-4 receptors; sympathetic nerve activity

Mesh:

Substances:

Year:  2016        PMID: 27791019      PMCID: PMC5087049          DOI: 10.1073/pnas.1607464113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  A role for the paraventricular nucleus of the hypothalamus in the autonomic control of heart and kidney.

Authors:  J H Coote
Journal:  Exp Physiol       Date:  2004-12-16       Impact factor: 2.969

2.  Melanocortin 3/4 receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure.

Authors:  Peng Li; Bai-Ping Cui; Ling-Li Zhang; Hai-Jian Sun; Tong-Yan Liu; Guo-Qing Zhu
Journal:  Exp Physiol       Date:  2012-08-07       Impact factor: 2.969

3.  Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic.

Authors:  W G Haynes; D A Morgan; A Djalali; W I Sivitz; A L Mark
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

Review 4.  Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin.

Authors:  J K Elmquist
Journal:  Int J Obes Relat Metab Disord       Date:  2001-12

5.  Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function.

Authors:  R S Ahima; D Prabakaran; J S Flier
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

Review 6.  The brain melanocortin system, sympathetic control, and obesity hypertension.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Zhen Wang; John E Hall
Journal:  Physiology (Bethesda)       Date:  2014-05

7.  Evidence of differential control of renal and lumbar sympathetic nerve activity in conscious rabbits.

Authors:  Rohit Ramchandra; Carolyn J Barrett; Sarah-Jane Guild; Simon C Malpas
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-10-20       Impact factor: 3.619

8.  Evidence for sympathetic origins of hypertension in juvenile offspring of obese rats.

Authors:  Anne-Maj Samuelsson; Abigail Morris; Natalia Igosheva; Shona L Kirk; Joaquim M C Pombo; Clive W Coen; Lucilla Poston; Paul D Taylor
Journal:  Hypertension       Date:  2009-11-09       Impact factor: 10.190

9.  Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice.

Authors:  Jussara M do Carmo; Lakshmi S Tallam; John V Roberts; Elizabeth L Brandon; John Biglane; Alexandre A da Silva; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-15       Impact factor: 3.619

10.  Role of nitric oxide in alpha-melanocyte-stimulating hormone-induced hypotension in the nucleus tractus solitarii of the spontaneously hypertensive rats.

Authors:  Ming-Hong Tai; Wen-Tsan Weng; Wan-Chen Lo; Julie Y H Chan; Che-Jen Lin; Hing-Chung Lam; Ching-Jiunn Tseng
Journal:  J Pharmacol Exp Ther       Date:  2007-02-05       Impact factor: 4.030

View more
  16 in total

1.  Melanocortin-4 Receptor Deficiency Attenuates Placental Ischemia-Induced Hypertension in Pregnant Rats.

Authors:  Frank T Spradley; Ana C Palei; Christopher D Anderson; Joey P Granger
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

Review 2.  Melanocortin-4 Receptors and Sympathetic Nervous System Activation in Hypertension.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Zhen Wang; John E Hall
Journal:  Curr Hypertens Rep       Date:  2019-04-26       Impact factor: 5.369

Review 3.  The melanocortin pathway and control of appetite-progress and therapeutic implications.

Authors:  Giulia Baldini; Kevin D Phelan
Journal:  J Endocrinol       Date:  2019-04-01       Impact factor: 4.286

4.  Lifestyle intervention in obese pregnancy and cardiac remodelling in 3-year olds: children of the UPBEAT RCT.

Authors:  Paul D Taylor; Haotian Gu; Hannah Saunders; Federico Fiori; Kathryn V Dalrymple; Priyanka Sethupathi; Liana Yamanouchi; Faith Miller; Bethany Jones; Matias C Vieira; Claire Singh; Annette Briley; Paul T Seed; Dharmintra Pasupathy; Paramala J Santosh; Alan M Groves; Manish D Sinha; Philip J Chowienczyk; Lucilla Poston
Journal:  Int J Obes (Lond)       Date:  2022-10-12       Impact factor: 5.551

5.  Maternal high-fat diet acts on the brain to induce baroreflex dysfunction and sensitization of angiotensin II-induced hypertension in adult offspring.

Authors:  Yu-Ping Zhang; Yan-Li Huo; Zhi-Qin Fang; Xue-Fang Wang; Jian-Dong Li; Hai-Ping Wang; Wei Peng; Alan Kim Johnson; Baojian Xue
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-26       Impact factor: 4.733

6.  Developmental Programming of Obesity and Liver Metabolism by Maternal Perinatal Nutrition Involves the Melanocortin System.

Authors:  Paul Cordero; Jiawei Li; Vi Nguyen; Joaquim Pombo; Nuria Maicas; Marco Novelli; Paul D Taylor; Anne-Maj Samuelsson; Manlio Vinciguerra; Jude A Oben
Journal:  Nutrients       Date:  2017-09-20       Impact factor: 5.717

7.  Reduced renal sympathetic nerve activity contributes to elevated glycosuria and improved glucose tolerance in hypothalamus-specific Pomc knockout mice.

Authors:  Kavaljit H Chhabra; Donald A Morgan; Benjamin P Tooke; Jessica M Adams; Kamal Rahmouni; Malcolm J Low
Journal:  Mol Metab       Date:  2017-07-17       Impact factor: 7.422

8.  Anomalous AMPK-regulated angiotensin AT1R expression and SIRT1-mediated mitochondrial biogenesis at RVLM in hypertension programming of offspring to maternal high fructose exposure.

Authors:  Yung-Mei Chao; Kay L H Wu; Pei-Chia Tsai; You-Lin Tain; Steve Leu; Wei-Chia Lee; Julie Y H Chan
Journal:  J Biomed Sci       Date:  2020-05-23       Impact factor: 8.410

9.  Hypothalamic MC4R regulates glucose homeostasis through adrenaline-mediated control of glucose reabsorption via renal GLUT2 in mice.

Authors:  Leticia Maria de Souza Cordeiro; Arwa Elsheikh; Nagavardhini Devisetty; Donald A Morgan; Steven N Ebert; Kamal Rahmouni; Kavaljit H Chhabra
Journal:  Diabetologia       Date:  2020-10-14       Impact factor: 10.122

Review 10.  Experimental Models of Maternal Obesity and Neuroendocrine Programming of Metabolic Disorders in Offspring.

Authors:  Clare M Reynolds; Stephanie A Segovia; Mark H Vickers
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-25       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.